April 13, 2018 / 4:34 AM / 8 months ago

BRIEF-Deinove Takes On A Whole New Dimension With The Acquisition Of Morphochem's Clinical Stage Antibiotic Compound

April 13 (Reuters) - Deinove SA:

* DEINOVE TAKES ON A WHOLE NEW DIMENSION WITH THE ACQUISITION OF MORPHOCHEM’S CLINICAL-STAGE ANTIBIOTIC COMPOUND

* DEINOVE SA- ANNOUNCES ACQUISITION, THROUGH A CONTRIBUTION-IN-KIND TRANSACTION, OF ENTIRE CAPITAL OF AUSTRIAN COMPANY BIOVERTIS AG

* DEINOVE SA- BIOVERTIS OWNS ENTIRE CAPITAL OF GERMAN COMPANY MORPHOCHEM, WITH LATTER DEVELOPING CLINICAL-STAGE ANTIBIOTIC COMPOUND “MCB3837” Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below